Former Indian Cricketer Anshuman Gaekwad Receives Rs 1 Crore for Cancer Treatment from BCCI
BCCI Secretary Jay Shah has come forward to support former India player and head coach Anshuman Gaekwad, who is battling blood cancer, with a financial assistance of Rs 1 crore.
Anshuman GaekwadBcciCancer TreatmentIndian CricketJay ShahReal Estate NewsJul 14, 2024
Anshuman Gaekwad, a former right-handed batter, has had an illustrious career, playing 40 Tests and 15 ODIs for India. He made his Test debut against the West Indies in December 1974 and scored 1985 runs in Test cricket at an average of 30.07, including 2 centuries and 10 half-centuries. His notable performance includes a score of 201 against Pakistan at Jalandhar in 1982-83.
Apart from the BCCI's financial assistance, a fund-raising effort is also being led by cricket legends Kapil Dev and Sunil Gavaskar. The 1983 World Cup-winning team, including players like Mohinder Amarnath and Ravi Shastri, has decided to contribute three months of their BCCI pension, totaling around Rs 50 lakh, to support Gaekwad's treatment.
This joint effort by the cricket fraternity is a testament to the support and solidarity that exists among the players, both past and present. It is heartening to see the BCCI and other cricketing legends coming forward to support Gaekwad in his time of need.
Information \nThe Board of Control for Cricket in India (BCCI) is the national governing body for cricket in India. It was established in 1928 and is responsible for governing and organizing cricket in the country. The BCCI is affiliated with the International Cricket Council (ICC) and is also a member of the Asian Cricket Council (ACC).
Frequently Asked Questions
Who is Anshuman Gaekwad?
Anshuman Gaekwad is a former Indian cricketer who played 40 Tests and 15 ODIs for India.
What is Anshuman Gaekwad suffering from?
Anshuman Gaekwad is suffering from blood cancer.
How much financial assistance has the BCCI provided to Anshuman Gaekwad?
The BCCI has provided Rs 1 crore to support Anshuman Gaekwad's cancer treatment.
Who is leading the fund-raising effort for Anshuman Gaekwad's treatment?
Cricket legends Kapil Dev and Sunil Gavaskar are leading the fund-raising effort for Anshuman Gaekwad's treatment.
How much has the 1983 World Cup-winning team contributed to Gaekwad's treatment?
The 1983 World Cup-winning team has contributed three months of their BCCI pension, totaling around Rs 50 lakh, to support Gaekwad's treatment.
Related News Articles
Revolutionizing the Future of Real Estate: Insights from Sushma's Building Business Summit
Industry leaders gather to discuss the future of commercial real estate, technology, and brand building at Sushma's Building Business Summit
5 Essential Checks to Ensure You Choose the Right Real Estate Agent in Maharashtra
From verifying MahaRERA registration to checking online reviews, here are the crucial checks to make before selecting a real estate agent in Maharashtra.
Festive Season Ignites a Boom in India's Real Estate Market
The festive season is not just about joy and celebration; it's also fueling a significant surge in India's real estate market. This upward trend is transforming the housing sector and driving growth in related industries.
Can a ₹50 Lakh Budget Buy You an Apartment in Mumbai? The Surprising Reality
If you've set aside ₹50 lakh to buy a property in Mumbai, you might be in for a surprise. While this amount might not be enough for a full apartment, it can get you something essential in the most sought-after areas. Read on to find out what.
Bombay High Court Stays REAT Order on Rs. 38.18 Cr Deposit in Real Estate Dispute
In a significant development, Justice Gauri Godse of the Bombay High Court has stayed an order by the Real Estate Appellate Tribunal (REAT) that directed a developer to deposit Rs. 38.18 crore in a real estate dispute.
Signature Global CEO Discusses Land Costs, Mid-Income Housing, and Margin Outlook
Signature Global, a prominent player in the real estate sector with a market capitalization of ₹15,278.43 crore, has faced a year of challenges, with its shares declining by nearly 14%. In a recent interview, the CEO shed light on the company's strategies